RWM
CLB icon

Raffa Wealth Management’s Core Laboratories CLB Stock Holding History

Raffa Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6
Closed -$720 – 468
2016
Q4 		$720 Hold
6
– – ﹤0.01% 563
2016
Q3 		$674 Hold
6
– – ﹤0.01% 576
2016
Q2 		$743 Hold
6
– – ﹤0.01% 495
2016
Q1 		$674 Hold
6
– – ﹤0.01% 546
2015
Q4 		$652 Hold
6
– – ﹤0.01% 547
2015
Q3 		$599 Hold
6
– – ﹤0.01% 580
2015
Q2 		$684 Hold
6
– – ﹤0.01% 529
2015
Q1 		$627 Buy
+6
New +$639 ﹤0.01% 585

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Raffa Wealth Management's CLB Position: Q1 2017 in Review

Raffa Wealth Management sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 6 shares — an estimated $720 sold.

Raffa Wealth Management first reported a position in CLB in Q1 2015 and held it in 8 quarters. The position peaked at $743 in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • Raffa Wealth Management reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • Raffa Wealth Management sold 6 Core Laboratories shares in Q1 2017, an estimated $720.
  • Raffa Wealth Management first reported a position in Core Laboratories in Q1 2015 and held it in 8 quarters.
  • Raffa Wealth Management's Core Laboratories position peaked at $743 in Q2 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Raffa Wealth Management's 13F filing for Q1 2017, filed 27 Jul 2026.